fbpx
April 17, 2024

Tainted Arthritis | Pain Products

FDA is notifying consumers of certain products promoted for arthritis and pain management that have been found to contain hidden ingredients and may pose a significant […]
April 17, 2024

Ossos-Sans contains hidden drug ingredients

[4-17-2024] The Food and Drug Administration is advising consumers not to purchase or use Ossos-Sans, a product promoted and sold for pain on various websites, including https://alnaturaleshop.com, […]
April 17, 2024

Regulatory Pharmaceutical Fellowship Program

Medication Safety Two-Year Medication Error Pharmacovigilance and Risk Management Fellowship provided by Butler University Fellowship dates: TBD, typical timeline shown below. Four months will be spent […]
April 16, 2024

Drug Safety Oversight Board

Background The DSB, created in 2005 and mandated by law in the FDA Amendments Act of 2007, advises the CDER Center Director on the handling and […]
April 16, 2024

FDA Roundup: April 16, 2024

For Immediate Release: April 16, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0